Related Experiment Video

Updated: Oct 12, 2025

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

17.8K

Decreased Incidence of Pediatric Intussusception during COVID-19

Jun Sung Park1, Young-Hoon Byun2, Seung Jun Choi1

  • 1Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

Children (Basel, Switzerland)
|November 27, 2021
PubMed

Insights

The COVID-19 pandemic reduced pediatric intussusception incidence, possibly due to fewer communicable diseases. However, cases that did occur were more severe, with higher rates of pathologic leading points and hospitalization.

Area of Science:

  • Pediatric Gastroenterology
  • Epidemiology
  • Infectious Diseases

Background:

  • The COVID-19 pandemic significantly altered disease patterns globally.
  • Understanding its impact on pediatric surgical emergencies like intussusception is crucial.

Purpose of the Study:

  • To investigate the epidemiologic and clinical changes in pediatric intussusception before and after the COVID-19 outbreak.
  • To explore the correlation between intussusception incidence and communicable diseases.

Main Methods:

  • Retrospective study of pediatric intussusception cases (ages ≤ 7 years) over two 1-year periods.
  • Comparison of disease incidence, patient demographics, and clinical severity markers pre- and post-pandemic.
  • Statistical analysis using Poisson log-linear regression.

Main Results:

  • A significant decrease in communicable diseases, non-communicable diseases, and intussusception incidence was observed post-pandemic.
  • Intussusception incidence correlated with the decline in communicable diseases (OR = 2.15, p = 0.029).
  • Pandemic-period patients had higher rates of pathologic leading points (PLP) and hospitalization, lower base excess, and higher lactate levels.

Conclusions:

  • The incidence of pediatric intussusception declined during the COVID-19 pandemic, potentially linked to reduced communicable disease transmission.
  • Despite lower overall incidence, intussusception cases during the pandemic were associated with increased severity and a higher proportion of PLPs.

Keywords:
COVID-19communicable diseaseepidemiologyintussusception

More Related Videos

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

1.5K
An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

3.7K

Related Concept Videos

Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
186
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
311
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
931
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
171
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.7K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
245